Mevo, a leading digital prescription platform in Brazil, announced today that it has raised $19 million USD (110 million BRL) in Series B funding. The round was led by Matrix Partners, with participation from Jefferson River Capital and existing investors, including Floating Point and IKJ Capital. Notable new investors include Elliot Cohen, former Amazon Pharmacy leader, and PillPack co-founder TJ Parker, who will also join Mevo’s board of directors.

Mevo revolutionizes healthcare in Brazil by allowing patients to easily access and manage prescriptions through a digital platform, replacing the traditional paper-based system. With over 10 million patients using the service and more than 80,000 pharmacies in Brazil accepting Mevo e-prescriptions, the platform aims to improve medication adherence and streamline the prescription process.

With this new funding, Mevo plans to expand its network of healthcare providers, enhance its digital pharmacy marketplace, and explore new healthcare services beyond prescription fulfillment.

Pedro Dias, CEO and co-founder of Mevo, highlighted the company’s mission to improve healthcare access across Brazil, stating, “This investment will allow us to continue expanding and improving the customer experience. Our goal is to make healthcare accessible for everyone in Brazil through their mobile devices.”

Mevo’s growing influence in the Brazilian healthcare system positions it to be a key player in modernizing healthcare delivery in the country.